ARCHIVES

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

This article is from The Cancer Letter archive.

Vol. 35 No. 28 | July 17, 2009

Download PDF Visit The Full Archive

Related Articles

DCT Get Okay to Proceed With Human Cell Line Drug Screening, More Drug Discovery Group

June 19, 1987

IOM appoints 22 to National Cancer Policy Forum.

July 1, 2005

Louis Sullivan Blasts Tobacco, Sports Links

May 10, 1991

Action Plan Steering committee votes 13-0 To Return $14 Million To NCI for Research

November 15, 1996

NTP Board Approves Concept For New Mutagenesis Assays

January 1, 1988

Study: Molecular Breast Imaging Can Be As Effective as MRI

July 27, 2012